Late onset acid maltase deficiency. Detection of patients and heterozygotes by urinary enzyme assay

Mark F. Mehler, S. DiMauro

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Daily urinary excretion of acid maltase (12.78 ± 2.10 units/24 hr/mg of creatinine, in 11 normal adults) was significantly decreased in ten patients with late onset acid maltase deficiency (1.33 ± 0.16 units/24 hr; P < .001) and 11 heterozygotes (3.27 ± 0.62 units/24 hr; P <.001). Maximal inhibition of urinary acid maltase activity by antibodies against human placental enzyme was 53% in controls, 30% in heterozygotes, and virtually absent in patients. Investigation of pH curves and enzyme inhibition by antibodies confirmed the presence in the kidney of an immunologically distinct 'extra' maltase enzyme active at acid pH. Whether acid maltase in normal urine originates in the kidney or cells of the lower urinary tract, the enzyme defect seems to be expressed in these cells in late onset acid maltase deficiency.

Original languageEnglish (US)
Pages (from-to)692-695
Number of pages4
JournalArchives of Neurology
Volume33
Issue number10
StatePublished - 1976
Externally publishedYes

Fingerprint

Heterozygote Detection
Glycogen Storage Disease Type II
alpha-Glucosidases
Enzyme Assays
Enzymes
Heterozygote
Kidney
Antibodies
Urinary Tract
Creatinine
Urine
Acids
Onset

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Late onset acid maltase deficiency. Detection of patients and heterozygotes by urinary enzyme assay. / Mehler, Mark F.; DiMauro, S.

In: Archives of Neurology, Vol. 33, No. 10, 1976, p. 692-695.

Research output: Contribution to journalArticle

@article{ee5a7cab997c4e9ba816645ba4db9bb5,
title = "Late onset acid maltase deficiency. Detection of patients and heterozygotes by urinary enzyme assay",
abstract = "Daily urinary excretion of acid maltase (12.78 ± 2.10 units/24 hr/mg of creatinine, in 11 normal adults) was significantly decreased in ten patients with late onset acid maltase deficiency (1.33 ± 0.16 units/24 hr; P < .001) and 11 heterozygotes (3.27 ± 0.62 units/24 hr; P <.001). Maximal inhibition of urinary acid maltase activity by antibodies against human placental enzyme was 53{\%} in controls, 30{\%} in heterozygotes, and virtually absent in patients. Investigation of pH curves and enzyme inhibition by antibodies confirmed the presence in the kidney of an immunologically distinct 'extra' maltase enzyme active at acid pH. Whether acid maltase in normal urine originates in the kidney or cells of the lower urinary tract, the enzyme defect seems to be expressed in these cells in late onset acid maltase deficiency.",
author = "Mehler, {Mark F.} and S. DiMauro",
year = "1976",
language = "English (US)",
volume = "33",
pages = "692--695",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "10",

}

TY - JOUR

T1 - Late onset acid maltase deficiency. Detection of patients and heterozygotes by urinary enzyme assay

AU - Mehler, Mark F.

AU - DiMauro, S.

PY - 1976

Y1 - 1976

N2 - Daily urinary excretion of acid maltase (12.78 ± 2.10 units/24 hr/mg of creatinine, in 11 normal adults) was significantly decreased in ten patients with late onset acid maltase deficiency (1.33 ± 0.16 units/24 hr; P < .001) and 11 heterozygotes (3.27 ± 0.62 units/24 hr; P <.001). Maximal inhibition of urinary acid maltase activity by antibodies against human placental enzyme was 53% in controls, 30% in heterozygotes, and virtually absent in patients. Investigation of pH curves and enzyme inhibition by antibodies confirmed the presence in the kidney of an immunologically distinct 'extra' maltase enzyme active at acid pH. Whether acid maltase in normal urine originates in the kidney or cells of the lower urinary tract, the enzyme defect seems to be expressed in these cells in late onset acid maltase deficiency.

AB - Daily urinary excretion of acid maltase (12.78 ± 2.10 units/24 hr/mg of creatinine, in 11 normal adults) was significantly decreased in ten patients with late onset acid maltase deficiency (1.33 ± 0.16 units/24 hr; P < .001) and 11 heterozygotes (3.27 ± 0.62 units/24 hr; P <.001). Maximal inhibition of urinary acid maltase activity by antibodies against human placental enzyme was 53% in controls, 30% in heterozygotes, and virtually absent in patients. Investigation of pH curves and enzyme inhibition by antibodies confirmed the presence in the kidney of an immunologically distinct 'extra' maltase enzyme active at acid pH. Whether acid maltase in normal urine originates in the kidney or cells of the lower urinary tract, the enzyme defect seems to be expressed in these cells in late onset acid maltase deficiency.

UR - http://www.scopus.com/inward/record.url?scp=0017085234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017085234&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 692

EP - 695

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 10

ER -